Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2586 | Visfatin | 1 | ng/mL | 3 | M-CSF | 168.0 | 79 | ||||
N2586 | PD184352 | 0.1 | uM | Visfatin | 1 | ng/mL | 3 | M-CSF | 159.0 | 75 | |
N2586 | Lestaurtinib | 0.3 | uM | Visfatin | 1 | ng/mL | 3 | M-CSF | 133.0 | 70 | |
N2586 | Ruxolitinib | 0.3 | uM | Visfatin | 1 | ng/mL | 3 | M-CSF | 150.5 | 62 | |
N2586 | Tofacitinib | 0.3 | uM | Visfatin | 1 | ng/mL | 3 | M-CSF | 155.0 | 64 | |
N2586 | IKK16 | 2.0 | uM | Visfatin | 1 | ng/mL | 3 | M-CSF | 146.0 | 59 | |
RA2159 | Leptin | 1 | ng/mL | 3 | M-CSF | 113.0 | 71 | ||||
RA2159 | PD184352 | 0.1 | uM | Leptin | 1 | ng/mL | 3 | M-CSF | 95.5 | 68 | |
RA2159 | Lestaurtinib | 0.3 | uM | Leptin | 1 | ng/mL | 3 | M-CSF | 89.0 | 67 | |
RA2159 | Ruxolitinib | 0.3 | uM | Leptin | 1 | ng/mL | 3 | M-CSF | 114.0 | 65 | |
RA2159 | Tofacitinib | 0.3 | uM | Leptin | 1 | ng/mL | 3 | M-CSF | 113.0 | 72 | |
RA2159 | IKK16 | 2.0 | uM | Leptin | 1 | ng/mL | 3 | M-CSF | 109.0 | 61 | |
N2586 | Leptin | 1 | ng/mL | 3 | M-CSF | 170.0 | 73 | ||||
N2586 | PD184352 | 0.1 | uM | Leptin | 1 | ng/mL | 3 | M-CSF | 184.0 | 98 | |
N2586 | Lestaurtinib | 0.3 | uM | Leptin | 1 | ng/mL | 3 | M-CSF | 140.0 | 60 | |
N2586 | Ruxolitinib | 0.3 | uM | Leptin | 1 | ng/mL | 3 | M-CSF | 160.0 | 60 | |
N2586 | Tofacitinib | 0.3 | uM | Leptin | 1 | ng/mL | 3 | M-CSF | 149.0 | 64 | |
N2586 | IKK16 | 2.0 | uM | Leptin | 1 | ng/mL | 3 | M-CSF | 130.5 | 40 | |
RA2159 | Adiponectin | 5 | ng/mL | 3 | M-CSF | 114.5 | 74 | ||||
RA2159 | PD184352 | 0.1 | uM | Adiponectin | 5 | ng/mL | 3 | M-CSF | 125.0 | 67 | |
RA2159 | Lestaurtinib | 0.3 | uM | Adiponectin | 5 | ng/mL | 3 | M-CSF | 141.5 | 74 | |
RA2159 | Ruxolitinib | 0.3 | uM | Adiponectin | 5 | ng/mL | 3 | M-CSF | 131.0 | 77 | |
RA2159 | Tofacitinib | 0.3 | uM | Adiponectin | 5 | ng/mL | 3 | M-CSF | 137.5 | 56 | |
RA2159 | IKK16 | 2.0 | uM | Adiponectin | 5 | ng/mL | 3 | M-CSF | 146.0 | 75 | |
N2586 | Adiponectin | 5 | ng/mL | 3 | M-CSF | 153.0 | 59 |